You are currently viewing a new version of our website. To view the old version click .

Bluetongue Virus: Pathogenesis and Vaccines

This special issue belongs to the section “Animal Viruses“.

Special Issue Information

Dear Colleagues,

Bluetongue virus (BTV) is a dsRNA virus (family Reoviridae, genus Orbivirus) transmitted by insect vectors (Culicoides spp.). BTV infects domestic and wild ruminants and causes high morbidity and mortality, mainly in sheep. Bluetongue is a World Organization for Animal Health (OIE) listed disease due to the great socioeconomic losses it inflicts. The presence of BTV has been documented on all continents except for Antarctica, reflecting the geographical expansion of Culicoides vectors. There are at least 29 BTV serotypes, which are based on the specific humoral response elicited against the VP2 protein. It has been shown that the reassortment of BTV RNA segments is responsible for the appearance of new virus strains.

Improved understanding of key factors involved in host tropism, immune response, and vaccine efficacy is required for the development of safe and potent new-generation BTV vaccines that have DIVA potential and are applicable to all serotypes (due to the frequent emergence of novel BTV serotypes). Therefore, this Special Issue welcomes all types of manuscripts (e.g., reviews, research articles, and short communications) addressing molecular mechanisms, host–virus interactions, pathogenicity, and vaccine strategies.

Dr. Noemí Sevilla
Dr. Veronica Martín
Dr. Jose M. Rojas
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • bluetongue virus
  • vaccines
  • pathogenesis
  • immune response
  • host tropism
  • host–virus interaction

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Viruses - ISSN 1999-4915